ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)

Biotechnologia Acta Т. 16, No. 6 , 2023
P.76-81, Bibliography 20, Engl.
UDC: 582.282.195.2:579.222
DOI:https://doi.org/10.15407/biotech16.06.076

Full text: (PDF, in English)

COMPLEXATION OF CURCUMIN WITH BOVINE SERUM ALBUMIN AND DIPHTHERIA TOXOID CRM197

Zhukova D.A., Hrabovskyi O.O.

Palladin Institute of biochemistry of the National Academy of Sciences of Ukraine, Kyiv

Aim. The goal of the study was to demonstrate the binding sites for curcumin on the protein carriers - bovine serum albumin and diphtheria toxoid CRM197. BSA was chosen as a potential non-specific protein carrier because of its wide use in medicine as a drug carrier.

Methods. In the investigation, both spectrophotometric and molecular docking methods were used.

Results. Two stable binding sites were demonstrated for BSA to bind curcumin. CRM197 was taken as a well-studied carrier protein with its antitumor activity. It has been investigated as a specific carrier with a high affinity for cancer cells with overexpression of the epidermal growth factor receptor.
Our results showed one possible curcumin binding site, making CRM197 an ideal specific curcumin delivery platform that provided at least an additive effect in anticancer therapies.

Conclusions. In conclusion, both studied proteins formed stable complexes with curcumin that could lay in the base of the commercial drug application.

Key words: curcumin, blood proteins, BSA, toxoid, CRM197, complex formation, macromolecular complexes, nanocomplex, protein structure, molecular docking.

© Palladin Institute of Biochemistry of National Academy of Sciences of Ukraine, 2023